Allogene Therapeutics, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 638 | 0.0% | 484,622 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 559 | 0.0% | 494,500 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 709 | 0.0% | 485,866 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,032 | 0.0% | 484,715 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,361 | 0.0% | 486,023 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,119 | 0.0% | 480,381 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 1,261 | 0.0% | 282,150 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 659 | 0.0% | 205,234 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 646 | 0.0% | 203,865 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,013 | 0.0% | 203,865 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 995 | 0.0% | 201,406 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 1,061 | 0.0% | 175,914 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 1,554 | 0.0% | 148,998 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 1,738 | 0.0% | 149,645 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 1,023 | 0.0% | 110,243 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 548 | 0.0% | 36,739 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 946 | 0.0% | 36,810 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 1,033 | 0.0% | 39,618 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 1,125 | 0.0% | 31,867 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 850 | 0.0% | 33,662 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,214 | 0.0% | 32,182 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 1,272 | 0.0% | 30,390 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 523 | 0.0% | 26,885 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 661 | 0.0% | 25,450 | 12/31/2019 |